Expression of HLA-DR is reduced in tumor infiltrating immune cells (TIICs) and regional lymph nodes of non-small-cell lung carcinomas. A putative mechanism of tumor-induced immunosuppression?

Anticancer Research

Volumn 21, Issue 4 A, 2001, Pages 2609-2615

  Foukas, P G ^a   Tsilivakos, V ^a   Zacharatos, P ^a   Mariatos, G ^a   Moschos, S ^a   Syrianou, A ^a   Asimacopoulos, P J ^a   Bramis, J ^a   Fotiadis, C ^a   Kittas, C ^a   Gorgoulis, V G ^a  

^a NONE   (Greece)

Author keywords

HLA DR; Immunosuppression; Lymph nodes; Non small cell lung cancer

Indexed keywords

HLA DR ANTIGEN; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

CARCINOMA, NON-SMALL-CELL LUNG; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPH NODES; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES;

EID: 0035152981     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones
2. MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness
3. Assembly, transport, and function of MHC class II molecules
4. Generation of class II antigen polymorphism
5. Macrophage Ia antigens. I. Macrophage populations differ in their expression of Ia antigens
6. Regulation of macrophage populations. V. Evaluation of the control of macrophage Ia expression in vitro
7. Post-transcriptional regulation of MHC class II expression in human T cells
8. Expression of Ia-like antigens in normal human nonlymphoid tissues
9. Evidence for function of Ia molecules on gut epithelial cells in man
10. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
11. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway
12. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction
13. Analysis of la antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor
14. Effect of IFN-gamma on the immune response in vivo and on gene expression in vitro
15. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens
16. Interleukin-10 (IL-10) and viral IL- I a 10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression
17. A new cytokine (IK) down-regulating HLA class II: Monoclonal antibodies, cloning and chromosome localization
18. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory, factor 1, and transforming growth factor beta
19. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, 1SGF3-gamma
20. Prostaglandins modulate macrophage Ia expression
21. Alpha-fetoprotein inhibits macrophage expression of la antigens
22. HLA class II expression in well differentiated thyroid carcinoma: Correlation with clinicopathological features
23. An evaluation of the prognostic significance of HLA-DR expression in axillary-node-negative breast cancer
24. CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion
25. Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration
26. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man
27. The role of B7 costimulation in T-cell immunity
28. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report
29. Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer
30. TIL from renal-cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity
31. The host- tumor immune conflict: From immunosuppression to resistance and destruction
32. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: Frequency and prognostic significance
33. Expression of HLA class I and II antigens in bronchogenic carcinomas: Its relationship to cellular DNA content and clinical-pathological parameters
34. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation
35. Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: Effect of tumor extirpation
36. Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma
37. Analysis of HLA-DR expression on keratinocytes in cervical neoplasia
38. Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma
39. Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma
40. Activated (HLA-DR+) T-lymphocyte subsets in early epithelial ovarian cancer and malignant ovarian germ cell tumors
41. Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival
42. Characterization of the mononuclear cell infiltrate and HLA-DR expression in 19 oligodendrogliomas
43. Accessory cells of the lung. II. Ia+ pulmonary dendritic cells display cell surface antigen heterogeneity
44. Reduction in HLA-DR antigen density on alveolar macrophages of smokers
45. Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis
46. Activation of alveolar macrophages in asymptomatic HIV-infected individuals
47. The effect of interferon-gamma and tumor necrosis factor-alpha on the expression of ICAM-1 and HLA-DR molecules on cells of a human germ cell neoplasm and their susceptibility to lysis by lymphokine-activated killer cells
48. HLA-DR antigen expression in colorectal carcinomas: Influence of expression by IFN-gamma in situ and its association with tumour progression
49. Biological implications of HLA-DR expression in tumours
50. Lack of class II trans-activator causes severe deficiency of HLA-DR expression in small cell lung cancer
51. Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients
52. Human non-small cell lung cancer cells express a type 2 cytokine pattern
53. Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small cell lung tumors
54. Progress in understanding the molecular pathogenesis of human lung cancer